Stoke Therapeutics STOK

$ 11.41 0.88%

Quarterly report 2024-Q3
added 11-05-2024

Stoke Therapeutics Balance Sheet 2011-2024 | STOK

Annual Balance Sheet Stoke Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-185 M	-108 M	-140 M	-287 M	-222 M	-105 M	-1.8 M	-	-	-	-	-	-
Long Term Debt	4.77 M	2.72 M	3.53 M	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	2.06 M	2.36 M	1.51 M	1.07 M	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	38 M	39.8 M	3.95 M	422 K	221 K	4 K	16 K	-	-	-	-	-	-
Total Current Liabilities	30.8 M	31.4 M	17.1 M	11.4 M	4.1 M	-	-	-	-	-	-	-	-
Total Liabilities	68.8 M	71.2 M	21.1 M	11.8 M	4.32 M	2.47 M	3.73 M	-	-	-	-	-	-
Deferred Revenue	15.3 M	14.9 M	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-402 M	-297 M	-196 M	-110 M	-58 M	-25.7 M	-13.2 M	-	-	-	-	-	-
Total Assets	228 M	256 M	239 M	298 M	229 M	108 M	2.44 M	-	-	-	-	-	-
Cash and Cash Equivalents	191 M	114 M	145 M	287 M	222 M	-	-	-	-	-	-	-	-
Book Value	160 M	185 M	218 M	286 M	224 M	105 M	-1.29 M	-	-	-	-	-	-
Total Shareholders Equity	160 M	185 M	218 M	286 M	224 M	105 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Stoke Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	3.01 M	3.55 M	4.12 M	-	819 K	1.46 M	2.09 M	-	3.32 M	3.91 M	3.14 M	3.53 M	3.92 M	683 K	20 K	80 K	296 K	584 K	868 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	11.3 M	20.6 M	29.2 M	38 M	41.7 M	44.9 M	36.4 M	39.8 M	44.7 M	49.5 M	53.1 M	3.95 M	4.37 M	1.18 M	333 K	422 K	422 K	422 K	422 K	221 K	221 K	221 K	221 K	4 K	4 K	4 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	61.2 M	65 M	64.8 M	68.8 M	66.9 M	66.7 M	68 M	71.2 M	73.5 M	77.1 M	76 M	21.1 M	16.3 M	9.38 M	6.44 M	11.8 M	11.8 M	11.8 M	11.8 M	4.32 M	4.32 M	4.32 M	4.32 M	2.47 M	2.47 M	2.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	31.6 M	26.1 M	20.9 M	15.3 M	8.74 M	8.06 M	13.5 M	14.9 M	12.8 M	10.6 M	8.47 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-480 M	-454 M	-428 M	-402 M	-375 M	-350 M	-320 M	-297 M	-271 M	-245 M	-221 M	-196 M	-172 M	-149 M	-127 M	-110 M	-110 M	-110 M	-110 M	-58 M	-58 M	-58 M	-58 M	-25.7 M	-25.7 M	-25.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	293 M	308 M	205 M	228 M	240 M	257 M	282 M	256 M	278 M	301 M	316 M	239 M	254 M	264 M	279 M	298 M	298 M	298 M	298 M	229 M	229 M	229 M	229 M	108 M	108 M	108 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	150 M	193 M	179 M	191 M	190 M	192 M	190 M	114 M	113 M	67.8 M	84.1 M	145 M	149 M	169 M	268 M	287 M	287 M	287 M	287 M	222 M	222 M	222 M	222 M	105 M	105 M	105 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	232 M	243 M	140 M	160 M	173 M	190 M	214 M	185 M	204 M	224 M	240 M	218 M	238 M	255 M	272 M	286 M	286 M	286 M	286 M	224 M	224 M	224 M	224 M	105 M	105 M	105 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	232 M	243 M	140 M	160 M	173 M	190 M	214 M	185 M	204 M	224 M	240 M	218 M	238 M	255 M	272 M	286 M	286 M	286 M	286 M	224 M	224 M	224 M	224 M	105 M	105 M	105 M	12.2 M	-1.29 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency